RECRUITING

Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a randomized controlled study of parents of children to be discharged from the neonatal intensive care unit at Bellevue and Elmhurst hospitals. A total of 425 subjects will be recruited across two sites over preparatory phases and two primary study phases.

Official Title

A Randomized, Controlled Study of a Health Literacy-informed Technology-based Approach to Support Safe Medication Use by Parents After Discharge of Infants From the Neonatal Intensive Care Unit.

Quick Facts

Study Start:2021-03-10
Study Completion:2026-02
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04278690

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. English or Spanish-speaking
  2. 2. 18 years of age and older
  3. 3. Child discharged home with a Rx for \>1 daily liquid medication (other than multivitamin)
  4. 4. Primary person who will administers child's medications.
  5. 5. Willingness and ability to participate
  1. 1. Does not have a working phone number
  2. 2. Does not have access to internet (via computer/smartphone)
  3. 3. Does not have a mobile phone that receives texts.
  4. 4. Not able to return to the hospital for their child's follow-up visit
  5. 5. Visual acuity worse than 20/50 according to the Rosenbaum Pocket Screener
  6. 6. Uncorrectable hearing impairment

Contacts and Locations

Study Contact

Hsiang Shonna Yin
CONTACT
646-501-4284
hsiang.yin@nyulangone.org
Jessica Velazquez-Perez
CONTACT
212-562-2821
jessica.velazquez@nyulangone.org

Principal Investigator

Hsiang Sharon Yin
PRINCIPAL_INVESTIGATOR
NYU Langone

Study Locations (Sites)

NYU Langone Health
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Hsiang Sharon Yin, PRINCIPAL_INVESTIGATOR, NYU Langone

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-03-10
Study Completion Date2026-02

Study Record Updates

Study Start Date2021-03-10
Study Completion Date2026-02

Terms related to this study

Additional Relevant MeSH Terms

  • Medication Administered in Error